Patients with end-stage renal disease suffer from complex hemostatic disorders. Uremic
patients show a bleeding diathesis that is mainly due to abnormalities of primary …

Patients with end‐stage renal disease (ESRD) develop hemostatic disorders mainly in the
form of bleeding diatheses. Hemorrhage can occur at cutaneous, mucosal, or serosal sites …

Patients with acute and chronic liver disease frequently acquire unique changes in
haemodynamic and haemostatic pathways that may result in life-threatening bleeding and …

Background—Contrast-induced acute kidney injury (CI-AKI), defined as a serum creatinine
increase≥ 0.5 mg/dL or≥ 25% within 72 hours after contrast exposure, is a common …

English language citations reporting complications of arteriovenous access for hemodialysis
are critically reviewed and discussed. Venous hypertension, arterial steal syndrome, and …

Normal hemostasis is initiated by damage of the vessel wall with exposure of subendothelial
structures to flowing blood and results in the formation of a solid hemostatic plug. The first …

The P2Y 12 receptor is a key player in platelet activation and represents an effective
pharmacological target for the inhibition of platelet aggregation and prevention of …

IN the pre-dialysis era clinical bleeding was a major manifestation of renal failure, so early
reports of patients with kidney diseases almost invariably alluded to haemorrhages. In …

Bleeding is a common and potentially serious complication of acute and chronic renal
failure. The pathogenesis of bleeding in uremia is multifactorial; however, the major role is …

Chronic kidney disease (CKD) is a pandemic public health problem, with 500 million people
worldwide estimated to have some form of kidney injury. 1 Survey data suggest that the …